BIOMARKERS IN CLINICAL DRUG DEVELOPMENT

Zapisane w:

Opis bibliograficzny
1. autor:	BLOOM J C (ED.)
Format:	Książka
Wydane:
Hasła przedmiotowe:	,
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

BIOMARKERS IN CLINICAL DRUG DEVELOPMENT
od: BLOOM JOHN C [E], DEAN ROBERT A. [E]
Wydane: (2003)

BIOMARKERS IN CLINICAL DRUG DEVELOPMENT
od: BLOOM JOHN C [E], DEAN ROBERT A. [E]
Wydane: (2003)

BIOMARKERS IN CLINICAL DRUG DEVELOPMENT VOL.132
od: BLOOM JOHN C
Wydane: (2003)

BIOMARKERS IN DRUG DEVELOPMENT
od: BLEAVINS MICHAEL
Wydane: (2010)

OUTSOURCING IN CLINICAL DRUG DEVELOPMENT
od: DRUCKER ROY [E], HUGHES GRAHAM [E]
Wydane: (2002)

FUNDAMENTALS OF EARLY CLINICAL DRUG DEVELOPMENT
od: ABDEL MAGID AHMED F (ED.)
Wydane: (2006)

DRUG PRODUCTS FOR CLINICAL TRIALS
od: MONKHOUSE DONALD C (ED.)
Wydane: (1998)

CLINICAL DRUG TRIAL AND TRIBULATIONS
od: CATO ALLEN (ED.)
Wydane: (2002)

Managing the clinical drug development process
od: Cocchetto, David
Wydane: (1992)

MANAGING THE CLINICAL DRUG DEVELOPMENT PROCESS
od: COCCHETTO DAVID M [A], NANDI RONALD V. [A]
Wydane: (1992)

MANAGING THE CLINICAL DRUG DEVELOPMENT PROCESS
od: COCCHETTO DAVID M [A], NARDI RONALD V. [A]
Wydane: (1992)

MANAGING THE CLINICAL DRUG DEVELOPEMENT PROCESS
od: COCCHETTO DAVID M
Wydane: (1992)

COMPUTER TECHNIQUES IN PRECLINICAL AND CLINICAL DRUG DEVELOPMENT
od: JACKSON ROBERT C
Wydane: (1996)

COMPUTER TECHNIQUE IN PRECLINICAL AND CLINICAL DRUG DEVELOPMENT
od: JACKSON ROBERT C [A]
Wydane: (1996)

NEW DRUG DEVELOPMENT : AN INTRODUCTION TO CLINICAL TRIALS
od: TURNER RICK J
Wydane: (2010)

DRUG PRODUCTS FOR CLINICAL TRIALS
od: MONKHOUSE DONALD C [E], RHODES C T [E]
Wydane: (1998)

Prognostic Utility Of Soluble Suppression Of Tumorigenicity (sST2) biomarker In Heart
od: Kar, Shubhra
Wydane: (2018)

Clinical drug trials and tribulations
od: Cato ,Allen
Wydane: (2002)

CLINICAL DRUG TRIALS AND TRIBULATIONMS
od: CATO ALLEN [E], SUTTON LYNDA [E], CATO III ALLEN [E]
Wydane: (2002)

Clinical pharmacology and drug therapy
od: Grahame-Smith, D.
Wydane: (2008)

POLYMER DRUGS IN THE CLINICAL STAGE
od: MAEDA HIROSHI
Wydane: (2003)

POLYMERIC DRUGS IN THE CLINICAL STAGE
od: MAEDA HIROSHI
Wydane: (2003)

MANAGING THE CLINICAL DRUG DEVELOPMENTPROCESS
od: COCCHETTO DAVID M
Wydane: (1992)

POLYMER DRUGS IN THE CLINICAL STAGE: ADVANTAGES AND PROSPECTS
od: MAEDA HIROSHI (ED.)
Wydane: (2003)

RECENT DEVELOPMENT IN THEREPEUTIC DRUG MONITORING AND CLINICAL TOXICOLOGY
od: SUNSHINE IRVING [E]
Wydane: (1992)

RECENT DEVELOPMENTS IN THERAPEUTIC DRUG MONITORING AND CLINICAL TOXICOLOGY
od: SUNSHINE IRVING
Wydane: (2019)

Recent developments in therapeutic drug monitoring & clinical toxicology
od: Sunshine,Irving
Wydane: (1992)

FUNDAMENTALS OF EARLY CLINICAL DRUG DEVELOPMENT VOL-142
od: ABDELMAGID AHMED
Wydane: (2006)

CLINICAL AUDIT IN PHARMACEUTICAL DEVELOPMENT
od: HAMRELL MICHAEL R (ED.)
Wydane: (2000)

DRUG PRODUCTS FOR CLINICAL TRIALS ,VOL-147
od: MONKHOUSE DONALD C.
Wydane: (2005)

COMPUTER TECHNIQUES IN PRECLINICAL AND CLINICAL DRUG DEV.
od: JACKSON ROBERT C
Wydane: (1996)

Managing clinically important drug interactions
od: Hansten,Phillip D
Wydane: (2003)

APPLIED THERAPEUTICS :THE CLINICAL USE OF DRUGS
od: KODA-KIMBLE MARY ANNE [E]
Wydane: (2005)

APPLIED THERAPEUTICS :THE CLINICAL USE OF DRUGS
od: KODA-KIMBLE MARY ANNE [E]
Wydane: (2005)

DRUG SAFETY ASSESSMENT IN CLINICAL TRIALS
od: BANAKAR UMESH V [A]
Wydane: (1991)

DRUG SAFETY ASSESSMENT IN CLINICAL TRIALS
od: GILBERT GENE S JED
Wydane: (1993)

IMMUNOTOXICOLOGY OF DRUGS AND CHEMICALS : AN EXPERIMENTAL AND CLINICAL APPROACH
od: DESCOTES J. [A]
Wydane: (2004)

NEW DRUG DEVELOPEMENT: REGULATORY PARADIGMS FOR CLINICAL PHARMACOLOGY AND BIOPHARMACEUTICS
od: SAHAJWALLA CHANDRAHAS G
Wydane: (2004)

NEW DRUG DEVELOPMENT
od: SAHAJWALLA CHANDRAHA G (ED.)

Exploring Interplay: Serum uric Acid Levels And Key Metabolic Biomarkers In Type -2 Diabetes Patients
od: Sen,Devanshi Rakesh
Wydane: (2024)